BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld
BioWorld
April 8, 1994
View Archived Issues
HYBRIDON OK'D FOR GEM 91 TRIAL
Read More
APPOINTMENTS AND ADVANCEMENTS
Read More
TARGETED GENETICS LICENSES AAV TECHNOLOGIES
Read More
AGENNIX PRODUCING COMMERCIALLY VIABLE LACTOFERRIN
Read More
SEPRACOR SPINOFF NETS $13M IN IPO
Read More
POLICY REVIEW CONTINUES ON GENETICALLY-ENGINEERED FOOD
Read More
TEXAS BIOTECH INTENDS TO BUY IPI
Read More
VIVUS IPO NETS $28M
Read More
WHY MEMORY LOSS IN ALZHEIMER'S PRECEDES TELLTALE AMYLOID PLAQUES
Read More
FDA APPROVES THALIDOMIDE TRIALS
Read More